Windtree Therapeutics has signed a $520 million new financing agreement, which will be used to purchase BNB.
BlockBeats News, July 25th, Nasdaq-listed biotechnology company Windtree Therapeutics (WINT) announced that it has entered into a share purchase agreement of up to $500 million to establish an Equity Line of Credit (ELOC). Additionally, the company has also signed an additional $20 million stock purchase agreement with Build and Build Corp.
The total funding size of this round reaches up to $520 million, with 99% of the funds to be used to purchase BNB. The company plans to officially start using the funds after obtaining shareholder approval to increase the number of authorized common shares.
You may also like
What you bought on CEX is really not US stocks: Analyzing the 94% liquidation monopoly and the evaporation of equity under a five-layer pipeline
In such a crowded cross-border payment arena, where is the next stop for the future?
Why Is Bitcoin Down in 2026? What We Can Learn From 2022
The large models in the United States are moving towards closure in the name of security
From the white-haired stock god to the billionaire fund mogul, the smart people shorting Nvidia are all getting rich using the same framework
Morning Report | CoinEx becomes a key hub for Iran to evade sanctions, involving over $3.8 billion in funds; Kalshi seeks a new round of financing, with a valuation potentially rising to $40 billion
Global Launch: As predictions become the most scarce asset in the AI era, Manadia is defining the next generation of the value internet
Why do cryptocurrency projects always like to change their names?
Who is footing the bill for the $64 billion accounting frenzy?
I never expected that the first application of AI x Crypto would be in security auditing
What is your view on Binance's competitive advantages?
ETH has entered a non-consensus phase, and the turning point is approaching!
The shift in the cloud of the air: from despising stablecoins a year ago to the high-profile entry of capital today
The survival dilemma of small and medium exchanges behind the withdrawal anomalies exposed by AscendEX
Why Is Bitcoin Falling Below $60K? 5 Key Market Drivers Explained
Bitcoin has dropped sharply amid ETF outflows, Strategy stock weakness, AI stock rallies, and changing Fed expectations. Explore the key forces driving BTC’s latest correction and what traders should watch next.


